Report overview
Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome (IBS) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome (IBS) Diagnostics. This report contains market size and forecasts of Irritable Bowel Syndrome (IBS) Diagnostics in global, including the following market information:
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Irritable Bowel Syndrome (IBS) Diagnostics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Laboratory Tests Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Irritable Bowel Syndrome (IBS) Diagnostics include Commonwealth Diagnostics International, Genova Diagnostics, Gemelli Biotech, Prometheus Laboratories, Inova Diagnostics, Inc., Biohit Oyj, Aerodiagnostics, LLC., Metabolic Solutions, Inc. and Sysmex Corporation, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Irritable Bowel Syndrome (IBS) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Irritable Bowel Syndrome (IBS) Diagnostics Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Segment Percentages, by Type, 2023 (%)
Laboratory Tests
Imaging Tests
Global Irritable Bowel Syndrome (IBS) Diagnostics Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Segment Percentages, by Application, 2023 (%)
Hospitals and Clinics
Diagnostic Centers
Others
Global Irritable Bowel Syndrome (IBS) Diagnostics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Irritable Bowel Syndrome (IBS) Diagnostics revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Irritable Bowel Syndrome (IBS) Diagnostics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Commonwealth Diagnostics International
Genova Diagnostics
Gemelli Biotech
Prometheus Laboratories
Inova Diagnostics, Inc.
Biohit Oyj
Aerodiagnostics, LLC.
Metabolic Solutions, Inc.
Sysmex Corporation
Buhlmann Laboratories AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Irritable Bowel Syndrome (IBS) Diagnostics, market overview.
Chapter 2: Global Irritable Bowel Syndrome (IBS) Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome (IBS) Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Irritable Bowel Syndrome (IBS) Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
